Migraine Management: 10 Evidence-Based Strategies for Prevention & Relief

Migraine is a disabling neurologic disorder affecting ~12% of adults. Effective management combines trigger identification, lifestyle optimization, acute treatment, and preventive therapy tailored to attack frequency and severity.

1. Identify & Track Triggers

Use a headache diary (app or paper) for ≥1 month. Common triggers: stress (let-down), hormonal fluctuations, sleep disruption, dehydration, missed meals, alcohol (red wine), caffeine changes, aged cheese, processed meats, MSG, strong odors, weather changes, bright/flickering light. Triggers are additive—threshold varies daily.

2. Consistent Daily Routine (The "Migraine Brain" Prefers Stability)

  • Sleep: Same bed/wake time ±30 min, 7–9 hours
  • Meals: Regular intervals, protein + complex carb, avoid fasting >4 hrs
  • Hydration: 2–3 L water/day; limit caffeine to <200 mg consistent daily
  • Exercise: 150+ min moderate aerobic/week (reduces frequency by ~30–50%)

3. Stress Management

  • Biofeedback (thermal, EMG) — Level A evidence for migraine prevention
  • Cognitive Behavioral Therapy (CBT) — addresses catastrophizing, pacing
  • Mindfulness/MBSR, progressive muscle relaxation, diaphragmatic breathing
  • Regular "micro-breaks" during work (20-20-20 rule: every 20 min, 20 ft away, 20 sec)

4. Acute Treatment: Treat Early, Treat Adequately

SeverityFirst-Line Options
Mild–ModerateNSAID (ibuprofen 400–600 mg, naproxen 500 mg) + antiemetic (metoclopramide 10 mg)
Moderate–Severe / NSAID failureTriptan (sumatriptan 50–100 mg PO, rizatriptan 10 mg ODT, eletriptan 40 mg) + NSAID
Nausea/vomiting prominentTriptan non-oral (sumatriptan SC 6 mg, nasal spray 20 mg) + antiemetic
Cardiovascular contraindicationsLasmiditan 50–100 mg, ubrogepant 50–100 mg, rimegepant 75 mg (gepants)

Limit acute meds to ≤2–3 days/week to avoid medication-overuse headache (MOH).

5. Preventive Therapy (If ≥4 headache days/month or disabling attacks)

  • Oral: Beta-blockers (propranolol, metoprolol), topiramate, valproate, candesartan, amitriptyline/venlafaxine
  • CGRP monoclonal antibodies (monthly/quarterly SC/IV): Erenumab, fremanezumab, galcanezumab, eptinezumab — high efficacy, tolerability
  • CGRP gepants (oral daily/alternate day): Atogepant, rimegepant — also approved for prevention
  • OnabotulinumtoxinA (Botox): Chronic migraine (≥15 headache days/mo); q12 weeks
  • Neuromodulation: Cefaly (supraorbital TENS), gammaCore (nVNS), Nerivio (remote electrical neuromodulation)

6. Rescue Plan for Breakthrough Attacks

  • Designated "migraine kit": medication, water, eye mask, earplugs, cold pack, ginger chews
  • Dark, quiet, cool room; avoid screens
  • Cold compress forehead/neck (15 min) or warm compress posterior neck
  • Hydration + electrolytes if vomiting

7. Comorbidity Management

Treat depression/anxiety, insomnia, obesity, sleep apnea, hypertension — all worsen migraine and limit treatment options.

8. Menstrual Migraine Strategies

  • Perimenstrual prevention: frovatriptan 2.5 mg BID or naproxen 550 mg BID starting 2 days before expected onset ×6 days
  • Continuous hormonal contraception (extended cycle) to reduce fluctuations

9. When to See a Specialist

  • ≥4 headache days/month, treatment failure, side effects, diagnostic uncertainty, pregnancy planning, need for advanced therapies

10. Support & Advocacy

  • Patient organizations: American Migraine Foundation, Miles for Migraine, CHAMP
  • Clinical trials: ClinicalTrials.gov for novel mechanisms (pituitary adenylate cyclase-activating peptide antibodies, etc.)

Migraine is manageable. A structured, proactive approach with a knowledgeable clinician transforms it from a controlling force to a manageable condition.

Migraine - Related Articles